In my opinion, HPV strains 16, 18, 31, and 35 should be included in the treatment plan. Together, these four strains account for nearly 80% of cervical cancers. Although treating these four strains would obviously be fairly expensive, it would be much less expensive than treating a patient who had developed cervical cancer, aside from being much better for the health of the patients.